Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) 3-Year EBITDA Growth Rate : 51.70% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Bio-Sincerity Pharma-Tech Co 3-Year EBITDA Growth Rate?

Hangzhou Bio-Sincerity Pharma-Tech Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.47.

During the past 12 months, Hangzhou Bio-Sincerity Pharma-Tech Co's average EBITDA Per Share Growth Rate was 52.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 51.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 53.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hangzhou Bio-Sincerity Pharma-Tech Co was 74.30% per year. The lowest was 39.80% per year. And the median was 51.70% per year.

Competitive Comparison of Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year EBITDA Growth Rate falls into.

Hangzhou Bio-Sincerity Pharma-Tech Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Hangzhou Bio-Sincerity Pharma-Tech Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

611 Dongguan Road, 2nd Floor, Building 8, Jinsheng Technology Park, Binjiang District, Hangzhou, CHN

Website

https://www.hzbio-s.com

Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Headlines

No Headlines